Will G. Roeffen
Nijmegen, GE 6500HB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings.
Journal: PLoS pathogens
Published: December 14, 2017
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.
Journal: Nature communications
Published: June 09, 2017
Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants for humoral responses.
Journal: Vaccine
Published: March 14, 2017
Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.
Journal: Pharmaceutical research
Published: February 28, 2017
Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine.
Journal: Microbial cell factories
Published: February 07, 2017
Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
Journal: Journal of nanobiotechnology
Published: February 25, 2016
Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen.
Journal: Vaccine
Published: December 09, 2015
Variation in susceptibility of African Plasmodium falciparum malaria parasites to TEP1 mediated killing in Anopheles gambiae mosquitoes.
Journal: Scientific reports
Published: October 16, 2015
Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.
Journal: Malaria journal
Published: September 11, 2015
A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.
Journal: Human vaccines & immunotherapeutics
Published: December 09, 2014
Last Updated: 09/26/2026